Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Leadership
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Offices
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Congressional and Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcment
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Search
  • Full Menu

Main Menu

  • Who We Are
  • What We Do
  • Careers
  • Resources
  • Submit A Tip
  • Get Updates
  • Scam Alert
  • English
  • ES

Drug Enforcement Administration

Robert J. Bell Special Agent in Charge
Chicago
@DEAChicagoDiv
April 29, 2022
Contact: Luis Agostini
Phone Number: 312-353-7875
For Immediate Release

Wisconsin Pharmacy to Pay Civil Penalty for Controlled Substance Dispensing and Record Keeping Violations

MADISON, Wis. – John G. McGarry, Assistant Special Agent in Charge of Drug Enforcement Administration-Wisconsin, and U.S. Attorney Timothy M. O’Shea, of the Western District of Wisconsin, announced today that Cadott Miller Pharmacy, Ltd., located in Cadott, Wisconsin, entered into a settlement agreement to pay $20,000 to resolve civil allegations that it violated the Controlled Substances Act (CSA) by dispensing controlled substances outside the usual course of professional pharmacy practice, among other CSA violations. 

As a registrant with the DEA, the CSA required the pharmacy to be both knowledgeable of and to adhere to federal and state statutes and regulations concerning the receipt, storage, recordkeeping, distribution, dispensing and destruction of controlled substances.

Between 2017 and 2019, the DEA executed several administrative inspection warrants to review the pharmacy’s operations. As part of the inspections, the DEA investigated the pharmacy’s practices regarding the receiving, dispensing and recordkeeping of controlled substances. On Dec. 17, 2019, after determining the pharmacy’s compliance measures were unsuccessful, DEA served an immediate suspension order of the pharmacy’s DEA Certificate of Registration, and Cadott Miller Pharmacy voluntarily surrendered its DEA registration on Jan. 7, 2020, for cause. As a result, the pharmacy has been unable to dispense controlled substances.

According to the government’s allegations set forth in the settlement agreement, Cadott Miller Pharmacy dispensed controlled substances outside the usual course of professional pharmacy practice by filling combinations of controlled substances and medications that have no legitimate medical purpose, are highly addictive, and were specifically combined to create or enhance abusive and euphoric effects. In addition, the government alleged that the pharmacy dispensed controlled substances with no valid prescription, provided unauthorized early refills, and dispensed Schedule II controlled substances for opioid dependence, which is prohibited under federal law.

In enacting the CSA, Congress recognized the importance of preventing the diversion of drugs from legitimate to illegitimate uses. The CSA, in relevant part, deters the illegal distribution, possession, dispensing, and improper use of controlled substances, all of which have contributed significantly to the opioid epidemic over the past two decades. The CSA therefore regulates all entities in the chain of distribution, including pharmacies and pharmacists. 

“Pharmacies that dispense controlled substances outside the course of professional pharmacy practice endanger the public, abuse their DEA registration, and violate federal law,” said U.S. Attorney O’Shea. “Pharmacies hold a public trust and grave responsibilities. The overwhelming majority of pharmacies closely adhere to federal and state law and are entirely deserving of the public’s trust. The U.S. Attorney’s Office will, however, gladly partner with DEA to protect the public when pharmacies violate federal law.”

“The men and women of the DEA, alongside our state and local partners, will continue keeping the citizens of Wisconsin safe from the reckless and unscrupulous practices of pharmacies that do not adhere to the Controlled Substances Act,” said DEA Wisconsin ASAC McGarry. 

According to the settlement agreement, the civil penalty amount was based on an inability to pay a substantial penalty and determined after analysis and review of the pharmacy’s financial circumstances. 

Assistant U.S. Attorney Leslie Herje represented the government in this matter. The DEA Milwaukee District Office primarily conducted the investigation, along with the United States Attorney’s Office Affirmative Civil Enforcement team. The settlement agreement states CSA allegations only; Cadott Miller Pharmacy denies the allegations. 

  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster